Podcasts about British Journal

In this episode, host and producer of The Psychology of Self-Injury podcast, Dr. Nicholas Westers, shares his own thoughts about how media portray nonsuicidal self-injury (NSSI) as well as suicide and mass shootings. He walks us through media guidelines for responsibly reporting and depicting each in the news, including the first ever NSSI media guidelines he published with ISSS colleagues. This marks the second solo episode of the podcast.Media Guidelines:Suicide: Read the suicide reporting guidelines published by the World Health Organization (WHO) here, learn about ethical reporting guidelines for media put forth by the American Foundation for Suicide Prevention (AFSP) here, and visit reportingonsuicide.org to review those offered by Suicide Awareness Voices of Education (SAVE).Mass Shootings: Read about media guidelines for responsible reporting on mass shootings put forth by the Radio Television Digital News Association (RTDNA) at www.rtdna.org/mass-shootings or visit reportingonmassshootings.org (this link is not currently active but could be reactivated in the future).Nonsuicidal Self-Injury (NSSI): Read about our International Society for the Study of Self-Injury (ISSS) media guidelines for NSSI and self-harm below. Watch Dr. Westers' interview with the British Journal of Psychiatry, the journal that published these guidelines here. See excellent resources provided by the Self-Injury & Recovery Resources (SIRR) at Cornell University at selfinjury.bctr.cornell.edu, including resources for the media here. Below are additional resources referenced in this episode.Westers, N. J., Lewis, S. P., Whitlock, J., Schatten, H. T., Ammerman, B., Andover, M. S., & Lloyd-Richardson, E. E.(2021). Media guidelines for the responsible reporting and depicting of non-suicidal self-injury. The British Journal of Psychiatry, 219(2), 415-418.Westers, N. J. (2024). Media representations of nonsuicidal self-injury. In E. E. Lloyd-Richardson, I. Baetens, & J. Whitlock (Eds.), The Oxford handbook of nonsuicidal self-injury (pp. 771-786). Oxford University Press.Phillips, D. P. (1974). The influence of suggestion on suicide: Substantive and theoretical implications of the Werther effect. American Sociological Review, 39(3), 340–354.Niederkrotenthaler, T., Voracek, M., Herberth, A., Till, B., Strauss, M., Etzersdorfer, E., Eisenwort, B., & Sonneck, G. (2010). Role of media reports in completed and prevented suicide: Werther v. Papageno effects. The British Journal of Psychiatry, 197(3), 234– 243.Follow Dr. Westers on Instagram and Twitter/X (@DocWesters). To join ISSS, visit itriples.org and follow ISSS on Facebook and Twitter/X (@ITripleS).The Psychology of Self-Injury podcast has been rated as one of the "10 Best Self Harm Podcasts" and "20 Best Clinical Psychology Podcasts" by Feedspot  and one of the Top 100 Psychology Podcasts by Goodpods. It has also been featured in Audible's "Best Mental Health Podcasts to Defy Stigma and Begin to Heal."

Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced ovarian cancer. TRANSCRIPT Dr. Linda Duska: Hello, and welcome to the ASCO Daily News Podcast. I am your guest host, Dr. Linda Duska. I am a professor of obstetrics and gynecology at the University of Virginia School of Medicine.  On today's episode, we will explore the management of advanced ovarian cancer, specifically with respect to a question that has really stirred some controversy over time, going all the way back more than 20 years: Should we be doing radical upfront surgery in advanced ovarian cancer, or should we be doing neoadjuvant chemotherapy? So, there was a lot of hype about the TRUST study, also called ENGOT ov33/AGO-OVAR OP7, a Phase 3 randomized study that compares upfront surgery with neoadjuvant chemotherapy followed by interval surgery. So, I want to talk about that study today. And joining me for the discussion is Dr. Kathleen Moore, a professor also of obstetrics and gynecology at the University of Oklahoma and the deputy director of the Stephenson Cancer Center, also at the University of Oklahoma Health Sciences.  Dr. Moore, it is so great to be speaking with you today. Thanks for doing this. Dr. Kathleen Moore: Yeah, it's fun to be here. This is going to be fun. Dr. Linda Duska: FYI for our listeners, both of our full disclosures are available in the transcript of this episode.  So let's just jump right in. We already alluded to the fact that the TRUST study addresses a question we have been grappling with in our field. Here's the thing, we have four prior randomized trials on this exact same topic. So, share with me why we needed another one and what maybe was different about this one? Dr. Kathleen Moore: That is, I think, the key question. So we have to level-set kind of our history. Let's start with, why is this even a question? Like, why are we even talking about this today? When we are taking care of a patient with newly diagnosed ovarian cancer, the aim of surgery in advanced ovarian cancer ideally is to prolong a patient's likelihood of disease-free survival, or if you want to use the term "remission," you can use the term "remission." And I think we can all agree that our objective is to improve overall survival in a way that also does not compromise her quality of life through surgical complications, which can have a big effect. The standard for many decades, certainly my entire career, which is now over 20 years, has been to pursue what we call primary cytoreductive surgery, meaning you get a diagnosis and we go right to the operating room with a goal of achieving what we call "no gross residual." That is very different – in the olden days, you would say "optimal" and get down to some predefined small amount of tumor. Now, the goal is you remove everything you can see.  The alternative strategy to that is neoadjuvant chemotherapy followed by interval cytoreductive surgery, and that has been the, quote-unquote, "safer" route because you chemically cytoreduce the cancer, and so, the resulting surgery, I will tell you, is not necessarily easy at all. It can still be very radical surgeries, but they tend to be less radical, less need for bowel resections, splenectomy, radical procedures, and in a short-term look, would be considered safer from a postoperative consideration. Dr. Linda Duska: Well, and also maybe more likely to be successful, right? Because there's less disease, maybe, theoretically. Dr. Kathleen Moore: More likely to be successful in getting to no gross residual. Dr. Linda Duska: Right. Yeah, exactly. Dr. Kathleen Moore: I agree with that. And so, so if the end game, regardless of timing, is you get to no gross residual and you help a patient and there's no difference in overall survival, then it's a no-brainer. We would not be having this conversation. But there remains a question around, while it may be more likely to get to no gross residual, it may be, and I think we can all agree, a less radical, safer surgery, do you lose survival in the long term by this approach? This has become an increasing concern because of the increase in rates of use of neoadjuvant, not only in this country, but abroad. And so, you mentioned the four prior studies. We will not be able to go through them completely. Dr. Linda Duska: Let's talk about the two modern ones, the two from 2020 because neither one of them showed a difference in overall survival, which I think we can agree is, at the end of the day, yes, PFS would be great, but OS is what we're looking for. Dr. Kathleen Moore: OS is definitely what we're looking for. I do think a marked improvement in PFS, like a real prolongation in disease-free survival, for me would be also enough. A modest improvement does not really cut it, but if you are really, really prolonging PFS, you should see that-  Dr. Linda Duska: -manifest in OS. Dr. Kathleen Moore: Yeah, yeah. Okay. So let's talk about the two modern ones. The older ones are EORTC and CHORUS, which I think we've talked about. The two more modern ones are SCORPION and JCOG0602. So, SCORPION was interesting. SCORPION was a very small study, though. So one could say it's underpowered. 170 patients. And they looked at only patients that were incredibly high risk. So, they had to have a Fagotti score, I believe, of over 9, but they were not looking at just low volume disease. Like, those patients were not enrolled in SCORPION. It was patients where you really were questioning, "Should I go to the OR or should I do neoadjuvant? Like, what's the better thing?" It is easy when it's low volume. You're like, "We're going." These were the patients who were like, "Hm, you know, what should I do?" High volume. Patients were young, about 55. The criticism of the older studies, there are many criticisms, but one of them is that, the criticism that is lobbied is that they did not really try. Whatever surgery you got, they did not really try with median operative times of 180 minutes for primary cytoreduction, 120 for neoadjuvant. Like, you and I both know, if you're in a big primary debulking, you're there all day. It's 6 hours. Dr. Linda Duska: Right, and there was no quality control for those studies, either. Dr. Kathleen Moore: No quality control. So, SCORPION, they went 451-minute median for surgery. Like, they really went for it versus four hours and then 253 for the interval, 4 hours. They really went for it on both arms. Complete gross resection was achieved in 50% of the primary cytoreduced. So even though they went for it with these very long surgeries, they only got to the goal half the time. It was almost 80% in the interval group. So they were more successful there. And there was absolutely no difference in PFS or OS. They were right about 15 months PFS, right about 40 months OS.  JCOG0602, of course, done in Japan, a big study, 300 patients, a little bit older population. Surprisingly more stage IV disease in this study than were in SCORPION. SCORPION did not have a lot of stage IV, despite being very bulky tumors. So a third of patients were stage IV. They also had relatively shorter operative times, I would say, 240 minutes for primary, 302 for interval. So still kind of short. Complete gross resection was not achieved very often. 30% of primary cytoreduction. That is not acceptable. Dr. Linda Duska: Well, so let's talk about TRUST. What was different about TRUST? Why was this an important study for us to see? Dr. Kathleen Moore: So the criticism of all of these, and I am not trying to throw shade at anyone, but the criticism of all of these is if you are putting surgery to the test, you are putting the surgeon to the test. And you are assuming that all surgeons are trained equally and are willing to do what it takes to get someone to no gross residual. Dr. Linda Duska: And are in a center that can support the post-op care for those patients. Dr. Kathleen Moore: Which can be ICU care, prolonged time. Absolutely. So when you just open these broadly, you're assuming everyone has the surgical skills and is comfortable doing that and has backup. Everybody has an ICU. Everyone has a blood bank, and you are willing to do that. And that assumption could be wrong. And so what TRUST said is, "Okay, we are only going to open this at centers that have shown they can achieve a certain level of primary cytoreduction to no gross residual disease." And so there was quality criteria. It was based on – it was mostly a European study – so ESGO criteria were used to only allow certified centers to participate. They had to have a surgical volume of over 36 cytoreductive surgeries per year. So you could not be a low volume surgeon. Your complete resection rates that were reported had to be greater than 50% in the upfront setting. I told you on the JCOG, it was 30%. Dr. Linda Duska: Right. So these were the best of the best. This was the best possible surgical situation you could put these patients in, right? Dr. Kathleen Moore: Absolutely. And you support all the things so you could mitigate postoperative complications as well. Dr. Linda Duska: So we are asking the question now again in the ideal situation, right? Dr. Kathleen Moore: Right. Dr. Linda Duska: Which, we can talk about, may or may not be generalizable to real life, but that's a separate issue because we certainly don't have those conditions everywhere where people get cared for with ovarian cancer. But how would you interpret the results of this study? Did it show us anything different? Dr. Kathleen Moore: I am going to say how we should interpret it and then what I am thinking about. It is a negative study. It was designed to show improvement in overall survival in these ideal settings in patients with FIGO stage IIIB and C, they excluded A, these low volume tumors that should absolutely be getting surgery. So FIGO stage IIIB and C and IVA and B that were fit enough to undergo radical surgery randomized to primary cytoreduction or neoadjuvant with interval, and were all given the correct chemo. Dr. Linda Duska: And they were allowed bevacizumab and PARP, also. They could have bevacizumab and PARP. Dr. Kathleen Moore: They were allowed bevacizumab and PARP. Not many of them got PARP, but it was distributed equally, so that would not be a confounder. And so that was important. Overall survival is the endpoint. It was a big study. You know, it was almost 600 patients. So appropriately powered. So let's look at what they reported. When they looked at the patients who were enrolled, this is a large study, almost 600 patients, 345 in the primary cytoreductive arm and 343 in the neoadjuvant arm. Complete resection in these patients was 70% in the primary cytoreductive arm and 85% in the neoadjuvant arm. So in both arms, it was very high. So your selection of site and surgeon worked. You got people to their optimal outcome. So that is very different than any other study that has been reported to date. But what we saw when we looked at overall survival was no statistical difference. The median was, and I know we do not like to talk about medians, but the median in the primary cytoreductive arm was 54 months versus 48 months in the neoadjuvant arm with a hazard ratio of 0.89 and, of course, the confidence interval crossed one. So this is not statistically significant. And that was the primary endpoint. Dr. Linda Duska: I know you are getting to this. They did look at PFS, and that was statistically significant, but to your point about what are we looking for for a reasonable PFS difference? It was about two months difference. When I think about this study, and I know you are coming to this, what I thought was most interesting about this trial, besides the fact that the OS, the primary endpoint was negative, was the subgroup analyses that they did. And, of course, these are hypothesis-generating only. But if you look at, for example, specifically only the stage III group, that group did seem to potentially, again, hypothesis generating, but they did seem to benefit from upfront surgery.  And then one other thing that I want to touch on before we run out of time is, do we think it matters if the patient is BRCA germline positive? Do we think it matters if there is something in particular about that patient from a biomarker standpoint that is different? I am hopeful that more data will be coming out of this study that will help inform this. Of course, unpowered, hypothesis-generating only, but it's just really interesting. What do you think of their subset analysis? Dr. Kathleen Moore: Yeah, I think the subsets are what we are going to be talking about, but we have to emphasize that this was a negative trial as designed. Dr. Linda Duska: Absolutely. Yes. Dr. Kathleen Moore: So we cannot be apologists and be like, "But this or that." It was a negative trial as designed. Now, I am a human and a clinician, and I want what is best for my patients. So I am going to, like, go down the path of subset analyses. So if you look at the stage III tumors that got complete cytoreduction, which was 70% of the cases, your PFS was almost 28 months versus 21.8 months. Dr. Linda Duska: Yes, it becomes more significant. Dr. Kathleen Moore: Yeah, that hazard ratio is 0.69. Again, it is a subset. So even though the P value here is statistically significant, it actually should not have a P value because it is an exploratory analysis. So we have to be very careful. But the hazard ratio is 0.69. So the hypothesis is in this setting, if you're stage III and you go for it and you get someone to no gross residual versus an interval cytoreduction, you could potentially have a 31% reduction in the rate of progression for that patient who got primary cytoreduction. And you see a similar trend in the stage III patients, if you look at overall survival, although the post-progression survival is so long, it's a little bit narrow of a margin.  But I do think there are some nuggets here that, one of our colleagues who is really one of the experts in surgical studies, Dr. Mario Leitao, posted this on X, and I think it really resonated after this because we were all saying, "But what about the subsets?" He is like, "It's a negative study." But at the end of the day, you are going to sit with your patient. The patient should be seen by a GYN oncologist or surgical oncologist with specialty in cytoreduction and a medical oncologist, you know, if that person does not give chemo, and the decision should be made about what to do for that individual patient in that setting. Dr. Linda Duska: Agreed. And along those lines, if you look carefully at their data, the patients who had an upfront cytoreduction had almost twice the risk of having a stoma than the patients who had an interval cytoreduction. And they also had a higher risk of needing to have a bowel resection. The numbers were small, but still, when you look at the surgical complications, as you've already said, they're higher in the upfront group than they are in the interval group. That needs to be taken into account as well when counseling a patient, right? When you have a patient in front of you who says to you, "Dr. Moore, you can take out whatever you want, but whatever you do, don't make me a bag." As long as the patient understands what that means and what they're asking us to do, I think that we need to think about that. Dr. Kathleen Moore: I think that is a great point. And I have definitely seen in our practice, patients who say, "I absolutely would not want an ostomy. It's a nonstarter for me." And we do make different decisions. And you have to just say, "That's the decision we've made," and you kind of move on, and you can't look back and say, "Well, I wish I would have, could have, should have done something else." That is what the patient wants. Ultimately, that patient, her family, autonomous beings, they need to be fully counseled, and you need to counsel that patient as to the site that you are in, her volume of disease, and what you think you can achieve. In my opinion, a patient with stage III cancer who you have the site and the capabilities to get to no gross residual should go to the OR first. That is what I believe. I do not anymore think that for stage IV. I think that this is pretty convincing to me that that is probably a harmful thing. However, I want you to react to this. I think I am going to be a little unpopular in saying this, but for me, one of the biggest take-homes from TRUST was that whether or not, and we can talk about the subsets and the stage III looked better, and I think it did, but both groups did really well. Like, really well. And these were patients with large volume disease. This was not cherry-picked small volume stage IIIs that you could have done an optimal just by doing a hysterectomy. You know, these were patients that needed radical surgery. And both did well. And so what it speaks to me is that anytime you are going to operate on someone with ovary, whether it be frontline, whether it be a primary or interval, you need a high-volume surgeon. That is what I think this means to me. Like, I would want high volume surgeon at a center that could do these surgeries, getting that patient, my family member, me, to no gross residual. That is important. And you and I are both in training centers. I think we ought to take a really strong look at, are we preparing people to do the surgeries that are necessary to get someone to no gross residual 70% and 85% of the time? Dr. Linda Duska: We are going to run out of time, but I want to address that and ask you a provocative question. So, I completely agree with what you said, that surgery is important. But I also think one of the reasons these patients in this study did so well is because all of the incredible new therapies that we have for patients. Because OS is not just about surgery. It is about surgery, but it is also about all of the amazing new therapies we have that you and others have helped us to get through clinical research. And so, how much of that do you think, like, for example, if you look at the PFS and OS rates from CHORUS and EORTC, I get it that they're, that they're not the same. It's different patients, different populations, can't do cross-trial comparisons. But the OS, as you said, in this study was 54 months and 48 months, which is, compared to 2010, we're doing much, much better. It is not just the surgery, it is also all the amazing treatment options we have for these patients, including PARP, including MIRV, including lots of other new therapies. How do you fit that into thinking about all of this? Dr. Kathleen Moore: I do think we are seeing, and we know this just from epidemiologic data that the prevalence of ovarian cancer in many of the countries where the study was done is increasing, despite a decrease in incidence. And why is that? Because people are living longer. Dr. Linda Duska: People are living longer, yeah. Dr. Kathleen Moore: Which is phenomenal. That is what we want. And we do have, I think, better supportive care now. PARP inhibitors in the frontline, which not many of these patients had. Now some of them, this is mainly in Europe, will have gotten them in the first maintenance setting, and I do think that impacts outcome. We do not have that data yet, you know, to kind of see what, I would be really interested to see. We do not do this well because in ovarian cancer, post-progression survival can be so long, we do not do well of tracking what people get when they come off a clinical trial to see how that could impact – you know, how many of them got another surgery? How many of them got a PARP? I think this group probably missed the ADC wave for the most part, because this, mirvetuximab is just very recently available in Europe. Dr. Linda Duska: Unless they were on trial. Dr. Kathleen Moore: Unless they were on trial. But I mean, I think we will have to see. 600 patients, I would bet a lot of them missed the ADC wave. So, I do not know that we can say we know what drove these phenomenal – these are some of the best curves we've seen outside of BRCA. And then coming back to your point about the BRCA population here, that is a really critical question that I do not know that we're ever going to answer. There have been hypotheses around a tumor that is driven by BRCA, if you surgically cytoreduced it, and then chemically cytoreduced it with chemo, and so you're starting PARP with nothing visible and likely still homogeneous clones. Is that the group we cured? And then if you give chemo first before surgery, it allows more rapid development of heterogeneity and more clonal evolution that those are patients who are less likely to be cured, even if they do get cytoreduced to nothing at interval with use of PARP inhibitor in the front line. That is a question that many have brought up as something we would like to understand better. Like, if you are BRCA, should you always just go for it or not? I do not know that we're ever going to really get to that. We are trying to look at some of the other studies and just see if you got neoadjuvant and you had BRCA, was anyone cured? I think that is a question on SOLO1 I would like to know the answer to, and I don't yet, that may help us get to that. But that's sort of something we do think about. You should have a fair number of them in TRUST. It wasn't a stratification factor, as I remember. Dr. Linda Duska: No, it wasn't. They stratified by center, age, and ECOG status Dr. Kathleen Moore: So you would hope with randomization that you would have an equal number in each arm. And they may be able to pull that out and do a very exploratory look. But I would be interested to see just completely hypothesis-generating what this looks like for the patients with BRCA, and I hope that they will present that. I know they're busy at work. They have translational work. They have a lot pending with TRUST. It's an incredibly rich resource that I think is going to teach us a lot, and I am excited to see what they do next. Dr. Linda Duska: So, outside of TRUST, we are out of time. I just want to give you a moment if there were any other messages that you want to share with our listeners before we wrap up. Dr. Kathleen Moore: It's an exciting time to be in GYN oncology. For so long, it was just chemo, and then the PARP inhibitors nudged us along quite a bit. We did move more patients, I believe, to the cure fraction. When we ultimately see OS, I think we'll be able to say that definitively, and that is exciting. But, you know, that is the minority of our patients. And while HRD positive benefits tremendously from PARP, I am not as sure we've moved as many to the cure fraction. Time will tell. But 50% of our patients have these tumors that are less HRD. They have a worse prognosis. I think we can say that and recur more quickly. And so the advent of these antibody-drug conjugates, and we could name 20 of them in development in GYN right now, targeting tumor-associated antigens because we're not really driven by mutations other than BRCA. We do not have a lot of things to come after. We're not lung cancer. We are not breast cancer. But we do have a lot of proteins on the surface of our cancers, and we are finally able to leverage that with some very active regimens. And we're in the early phases, I would say, of really understanding how best to use those, how best to position them, and which one to select for whom in a setting where there is going to be obvious overlap of the targets. So we're going to be really working this problem. It is a good problem. A lot of drugs that work pretty well. How do you individualize for a patient, the patient in front of you with three different markers? How do you optimize it? Where do you put them to really prolong survival? And then we finally have cell surface. We saw at ASCO, CDK2 come into play here for the first time, we've got a cell cycle inhibitor. We've been working on WEE1 and ATR for a long time. CDK2s may hit. Response rates were respectable in a resistant population that was cyclin E overexpressing. We've been working on that biomarker for a long time with a toxicity profile that was surprisingly clean, which I like to see for our patients. So that is a different platform. I think we have got bispecifics on the rise. So there is a pipeline of things behind the ADCs, which is important because we need more than one thing, that makes me feel like in the future, I am probably not going to be using doxil ever for platinum-resistant disease. So, I am going to be excited to retire some of those things. We will say, "Remember when we used to use doxil for platinum-resistant disease?" Dr. Linda Duska: I will be retired by then, but thanks for that thought. Dr. Kathleen Moore: I will remind you. Dr. Linda Duska: You are right. It is such an incredibly exciting time to be taking care of ovarian cancer patients with all the opportunities.  And I want to thank you for sharing your valuable insights with us on this podcast today and for your great work to advance care for patients with GYN cancers. Dr. Kathleen Moore: Likewise. Thanks for having me. Dr. Linda Duska: And thank you to our listeners for your time today. You will find links to the TRUST study and other studies discussed today in the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:   Dr. Linda Duska  @Lduska Dr. Kathleen Moore Follow ASCO on social media:     @ASCO on X (formerly Twitter) ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures of Potential Conflicts of Interest:    Dr. Linda Duska:   Consulting or Advisory Role: Regeneron, Inovio Pharmaceuticals, Merck, Ellipses Pharma  Research Funding (Inst.): GlaxoSmithKline, Millenium, Bristol-Myers Squibb, Aeterna Zentaris, Novartis, Abbvie, Tesaro, Cerulean Pharma, Aduro Biotech, Advaxis, Ludwig Institute for Cancer Research, Leap Therapeutics  Patents, Royalties, Other Intellectual Property: UptToDate, Editor, British Journal of Ob/Gyn  Dr. Kathleen Moore: Leadership: GOG Partners, NRG Ovarian Committee Chair Honoraria: Astellas Medivation, Clearity Foundation, IDEOlogy Health, Medscape, Great Debates and Updates, OncLive/MJH Life Sciences, MD Outlook, Curio Science, Plexus, University of Florida, University of Arkansas for Medical Sciences, Congress Chanel, BIOPHARM, CEA/CCO, Physician Education Resource (PER), Research to Practice, Med Learning Group, Peerview, Peerview, PeerVoice, CME Outfitters, Virtual Incision Consulting/Advisory Role: Genentech/Roche, Immunogen, AstraZeneca, Merck, Eisai, Verastem/Pharmacyclics, AADi, Caris Life Sciences, Iovance Biotherapeutics, Janssen Oncology, Regeneron, zentalis, Daiichi Sankyo Europe GmbH, BioNTech SE, Immunocore, Seagen, Takeda Science Foundation, Zymeworks, Profound Bio, ADC Therapeutics, Third Arc, Loxo/Lilly, Bristol Myers Squibb Foundation, Tango Therapeutics, Abbvie, T Knife, F Hoffman La Roche, Tubulis GmbH, Clovis Oncology, Kivu, Genmab/Seagen, Kivu, Genmab/Seagen, Whitehawk, OnCusp Therapeutics, Natera, BeiGene, Karyopharm Therapeutics, Day One Biopharmaceuticals, Debiopharm Group, Foundation Medicine, Novocure Research Funding (Inst.): Mersana, GSK/Tesaro, Duality Biologics, Mersana, GSK/Tesaro, Duality Biologics, Merck, Regeneron, Verasatem, AstraZeneca, Immunogen, Daiichi Sankyo/Lilly, Immunocore, Torl Biotherapeutics, Allarity Therapeutics, IDEAYA Biosciences, Zymeworks, Schrodinger Other Relationship (Inst.): GOG Partners

-> This episode is an extract from an interview. You will find the entire interview on this same account.In this episode, we talk with Diane Smyth, editor at the British Journal of Photography and an established writer and lecturer based in London. Alongside her role at BJP, Diane contributes to major publications such as The Guardian, FT Weekend Magazine, Aperture, Foam, and Apollo. She also collaborates with Photoworks, where she has contributed as an editor and writer. Diane teaches history and theory of photography at the London College of Communication and has curated exhibitions for The Photographers' Gallery and the Lianzhou Foto Festival.With Diane, we discuss her career path, her editorial practice, and how she approaches working with photographers. She also shares her thoughts on the shifts in photography over the past fifteen years, and offers advice for photographers, writers, and editors who want to better understand the editorial world.Enjoy the episode!British Journal of Photography's website: https://www.1854.photography/Diane's Intagram account: https://www.instagram.com/dismy/?hl=frLink to my questionnaire to help you reflect on your artistic career: https://bit.ly/carriereartistiqueLien vers mon questionnaire pour vous aider à faire un point sur votre projet de livre : https://bit.ly/LVDLPlivrephotoMy website: https://marinelefort.fr/To subscribe to the podcast newsletter: https://bit.ly/lesvoixdelaphotonewsletterPodcast website: https://lesvoixdelaphoto.fr/You can also follow the podcast on Instagram, Facebook, and LinkedIn @lesvoixdelaphotoLes Voix de la Photo is a podcast produced and hosted by Marine Lefort. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Welcome back to the BJN podcast. In this episode, Sean Boyle (Editor, British Journal of Nursing) sits down with returning guest Nicki Thomas (Kidney Nurse and Professor at London South Bank University) and Doctor Patricia Smith (Senior Lecturer at University of East London and Physiotherapist in Allied and Public Health) to discuss the science behind exercise and kidney health, the barriers that prevent people from being active, and the practical steps nurses can take to empower individuals and communities to reduce their risk of kidney disease and diabetes through movement and lifestyle change. We're always keen to hear your feedback! If you'd like to share your thoughts on today's epsiode, drop us an email at: bjn@markallengroup.com  Like what you've heard here today? Check out the BJN website for more information on all things nursing: https://www.britishjournalofnursing.com/  The BJN podcast was edited by Tom Austin-Morgan: https://www.linkedin.com/in/thomasaustinmorgan/ 

In this episode, we talk with Diane Smyth, editor at the British Journal of Photography and an established writer and lecturer based in London. Alongside her role at BJP, Diane contributes to major publications such as The Guardian, FT Weekend Magazine, Aperture, Foam, and Apollo. She also collaborates with Photoworks, where she has contributed as an editor and writer. Diane teaches history and theory of photography at the London College of Communication and has curated exhibitions for The Photographers' Gallery and the Lianzhou Foto Festival.With Diane, we discuss her career path, her editorial practice, and how she approaches working with photographers. She also shares her thoughts on the shifts in photography over the past fifteen years, and offers advice for photographers, writers, and editors who want to better understand the editorial world.Enjoy the episode!01:30 – Diane Smyth's academic background: from literature to photography05:45 – Joining the British Journal of Photography11:10 – What it means to be an editor: working with photographers and shaping stories15:40 – Collaborating with Photoworks: editing projects and contributing as a writer17:20 – Writing across formats: magazines, catalogues, and books22:50 – Editing at BJP today: curating issues and defining editorial directions28:15 – Teaching at London College of Communication: guiding new generations of photographers34:00 – How photography has shifted in the last 10–15 years44:30 – Balancing roles: editor, writer, lecturer49:50 – Advice for aspiring editors, writers, and photographersBritish Journal of Photography's website: https://www.1854.photography/Diane's Intagram account: https://www.instagram.com/dismy/?hl=frLink to my questionnaire to help you reflect on your artistic career: https://bit.ly/carriereartistiqueLien vers mon questionnaire pour vous aider à faire un point sur votre projet de livre : https://bit.ly/LVDLPlivrephotoMy website: https://marinelefort.fr/To subscribe to the podcast newsletter: https://bit.ly/lesvoixdelaphotonewsletterPodcast website: https://lesvoixdelaphoto.fr/You can also follow the podcast on Instagram, Facebook, and LinkedIn @lesvoixdelaphotoLes Voix de la Photo is a podcast produced and hosted by Marine Lefort. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

In this episode, Sharona and Boz follow up on episode 121 and sit down with Dr. Sharon Stranford, Professor of Biology at Pomona College, to explore her journey from traditional grading toward ungrading and collaborative grading in STEM. Sharon shares how her experiences as a first-generation college student, a long-time practitioner of just-in-time teaching, and a pandemic-era educator led her to reimagine how feedback, mastery, and motivation intersect in the science classroom.She explains how she replaced numbers and letters with meaningful dialogue, feedback, and self-assessment, helping students shift from “What's my grade?” to “What have I learned?” Along the way, she describes how personal goals, SMART reflections, and one-on-one mastery conversations help students develop agency and persistence—while also transforming the teacher–student relationship.LinksPlease note - any books linked here are likely Amazon Associates links. Clicking on them and purchasing through them helps support the show. Thanks for your support!Just-In-Time Teaching: Blending Active Learning with Web Technology, Novak, G. Et AlEnhancing and Undermining Intrinsic Motivation: The Effects of Task-Involving and Ego-Involving Evaluation on Interest and Performance.British Journal of Educational Psychology. Butler, R, Et AlResourcesThe Center for Grading Reform - seeking to advance education in the United States by supporting effective grading reform at all levels through conferences, educational workshops, professional development, research and scholarship, influencing public policy, and community building.The Grading Conference - an annual, online conference exploring Alternative Grading in Higher Education & K-12.Some great resources to educate yourself about Alternative Grading:The Grading for Growth BlogThe Grading ConferenceThe Intentional Academia BlogRecommended Books on Alternative Grading:Grading for Growth, by Robert Talbert and David ClarkSpecifications Grading, by Linda Nilsen

Welcome back to the BJN podcast. In this episode, Sean Boyle (Editor, British Journal of Nursing) sits down with Lindsay Hinson (Practice Development Nurse and Clinical Practitioner) to discuss the nature of prison nursing as a profession, the current issues the prison system is experiencing, and how nurses navigate the complex nature of prison-centred patient care.  The conversation explores Lindsay's experience as a prison nurse, why she believes in prison nursing as a profession, and what needs to change in the government's current strategies relating to prison health and wellbeing. We're always keen to hear your feedback! If you'd like to share your thoughts on today's epsiode, drop us an email at: bjn@markallengroup.com  Like what you've heard here today? Check out the BJN website for more information on all things nursing: https://www.britishjournalofnursing.com/  The BJN podcast was edited by Tom Austin-Morgan: https://www.linkedin.com/in/thomasaustinmorgan/ 

MOPs & MOEs is powered by TrainHeroic, the best coaching app on the planet. ⁠⁠⁠Click here to get 14 days FREE and a consult with the coaches at TrainHeroic to help you get your coaching business rolling on TrainHeroic. ⁠⁠⁠ MOPs & MOEs delivers our training through ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TrainHeroic and you can ⁠⁠⁠get your first 7 days of training with us FREE by clicking here.⁠⁠⁠To continue the conversation, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠join our Discord!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We have experts standing by to answer your questions.Dr. Rich Willy is a new Associate Professor in the PhD program in the School of Health and Rehabilitation Sciences at The Ohio State University. He holds a PhD in Biomechanics and Movement Science from the University of Delaware and a Master's of Physical Therapy from Ohio University. He is a licensed physical therapist with over two decades of clinical and academic experience. His research focuses on the biomechanics of running-related injuries, bone stress injuries, and rehabilitation strategies for tactical and athletic populations.Dr. Willy has authored more than 80 peer-reviewed publications and book chapters, and his work has been featured in high-impact journals such as British Journal of Sports Medicine, Journal of Orthopaedic & Sports Physical Therapy, and American Journal of Sports Medicine. Dr. Willy contributes to clinical practice guidelines for patellofemoral pain and running injuries. He is a frequently invited speaker at national and international conferences, including symposia for the US and International Olympic Committees, NBA teams, and sports medicine meetings.His research has been supported by the Department of Defense and APTA Orthopaedics, among others. Current projects include optimizing load carriage biomechanics, developing sex-specific training interventions, and advancing wearable technologies for injury prevention and rehabilitation.He and his wife also run Montana Running Lab, a hugely valuable resource curating the best clinical evidence for athletes and rehab professionals. We highly recommend their instagram as an evidence based source of information. We'll talk a bit about some of the resources available there at the end of this episode.

In 1865, German physician and medical writer Justus Hecker published a volume titled The Epidemics of the Middle Ages. In a footnote, he remarked on a strange phenomenon: an outbreak of meowing nuns. In this minisode, I bring you the story of the meowing nuns of late medieval France and the men who told their story.Researched, written, and produced by Corinne Wieben with original music by Purple Planet.SourcesPrimaryAristotle. History of Animals. Translated by d' A. W. Thompson. In Aristotle, Complete Works. Vol. 1, 774–993. Princeton, NJ: Princeton University Press, 1984.Aristotle. Politics. Translated by Ernest Barker. Oxford: Oxford University Press, 1977.Hecker, J. F. C. The Epidemics of the Middle Ages. Translated by B. G. Babington. London: Woodfall, 1844. Zimmerman, J. G. Solitude. Vol. II. London: Dilly, 1798.SecondaryBartholomew, Robert E. Little Green Men, Meowing Nuns and Head-Hunting Panics: A Study of Mass Psychogenic Illness and Social Delusion. London: McFarland, 2001.Bartholomew, Robert E. and Simon Wessely. “Protean Nature of Mass Sociogenic Illness: From Possessed Nuns to Chemical and Biological Terrorism Fears.” British Journal of Psychiatry 180, no. 4 (2002): 300–306.Mercer, Christia. “The Philosophical Roots of Western Misogyny.” Philosophical Topics 46, no. 2 (2018): 183–208.Penso G. Roman Medicine. 3rd ed. Noceto: Essebiemme, 2002.Tasca, Cecilia et al. “Women and Hysteria in the History of Mental Health.” Clinical Practice and Epidemiology in Mental Health 8 (2012): 110-9.Support the showEnchantedPodcast.netBluesky/enchantedpodcast.net

Welcome back to the BJN podcast. In this episode, Sean Boyle (Editor, British Journal of Nursing) sits down with Natasha Rolls (Lead Stoma Care Nurse and Honorary Treasurer of the Association of Stoma Care Nurses UK) to discuss the current landscape of stoma care nursing, how the NHS Long Term plan will impact the profession and what information nurses need to know to adapt to future changes.  The conversation explores what the profession looks like today, how upcoming NHS strategies may reshape it, and what innovations could transform stoma care in the next few years.   We're always keen to hear your feedback! If you'd like to share your thoughts on today's epsiode, drop us an email at: bjn@markallengroup.com  Like what you've heard here today? Check out the BJN website for more information on all things nursing: https://www.britishjournalofnursing.com/  The BJN podcast was edited by Tom Austin-Morgan: https://www.linkedin.com/in/thomasaustinmorgan/ 

¿Entrenas, comes bien y aun así no ganas músculo? En este video entenderás por qué ocurre y qué puedes hacer para cambiarlo. Te explico las 7 claves para ganar músculo rápido, de forma natural y basada en ciencia. Tu cuerpo no está diseñado para ganar músculo fácilmente, por evolución, prefiere ahorrar energía y almacenar grasa, pero con las estrategias correctas puedes reprogramarlo y hacerlo trabajar a tu favor.

A study in the British Journal of Psychiatry supports what some mothers' groups have known for a while - group singing helps with postnatal depression. 

In this episode, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, dives deep into estrone, one of the three key estrogens, and explains why understanding it is crucial for women's health. Learn about: The differences between estradiol, estriol, and estrone How estrone levels shift during perimenopause and menopause Why oral estrogen can dramatically increase estrone The impact of lifestyle factors like diet, body fat, stress, alcohol, and sedentary behavior on estrogen balance Practical tips to support healthy estrogen metabolism naturally Dr. McCarthy breaks down complex biochemistry in a clear, actionable way so you can take charge of your hormonal health.   Citations: 1. Bulun, Serdar E., et al. “Aromatase and Estrogen Biosynthesis in Adipose Tissue.” Endocrine Reviews, vol. 23, no. 3, 2002, pp. 305–342. 2. Labrie, Fernand, et al. “Importance of the Intracrinology of Estrogen Synthesis in Peripheral Tissues in Postmenopausal Women.” Journal of Steroid Biochemistry and Molecular Biology, vol. 118, nos. 4–5, 2010, pp. 273–279. 3. Sasano, Hironobu, and Toshihiko Harada. “Differential Expression of Aromatase and 17β-Hydroxysteroid Dehydrogenase Isoenzymes in Human Tissues.” Journal of Steroid Biochemistry and Molecular Biology, vol. 86, no. 3–5, 2003, pp. 327–333. 4. Yager, James D., and Nancy E. Davidson. “Estrogen Carcinogenesis in Breast Cancer.” New England Journal of Medicine, vol. 354, no. 3, 2006, pp. 270–282. 5. Cavalieri, Ercole L., and Eleanor G. Rogan. “Depurinating Estrogen-DNA Adducts, Mechanisms of Formation, and Prevention.” Clinical Cancer Research, vol. 16, no. 3, 2010, pp. 596–602. 6. Suba, Zsuzsanna. “Circulating Estrogens and Estrogen Metabolism in Obese Women.” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 11, 2013, pp. 4336–4344. 7. Simpson, Evan R., and Konstanze C. Pike. “Aromatase Expression in Adipose Tissue: Relationship to Obesity and Insulin Resistance.” Endocrinology, vol. 156, no. 9, 2015, pp. 3422–3435. 8. Key, Timothy J., et al. “Circulating Sex Hormones and Breast Cancer Risk Factors in Postmenopausal Women: Reanalysis of 13 Studies.” British Journal of Cancer, vol. 105, no. 5, 2011, pp. 709–722. 9. Stanczyk, Frank Z., et al. “Oral, Transdermal and Injectable Hormone Therapy: Pharmacokinetics and Effects on Estrone/Estradiol Ratios.” Menopause, vol. 24, no. 9, 2017, pp. 1080–1090. 10. Santen, Richard J., et al. “Estrogen Bioidentical Hormone Therapy: Route of Administration and Risk.” Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 7, 2020, pp. 2062–2074. 11. Zeleniuch-Jacquotte, Anne, et al. “Postmenopausal Levels of Estrone, Estradiol, and Estrone Sulfate and Breast Cancer Risk.” Cancer Epidemiology, Biomarkers & Prevention, vol. 23, no. 8, 2014, pp. 1531–1539. 12. Dall, Gabriella V., and Christine L. Clarke. “Local Estrogen Biosynthesis and Signaling in Breast Cancer Progression.” Steroids, vol. 78, no. 7, 2013, pp. 639–646. 13. Heald, Anthony H., et al. “Relationships Between Serum Estrone, Insulin Resistance, and Adiposity in Postmenopausal Women.” Clinical Endocrinology, vol. 67, no. 3, 2007, pp. 340–345. 14. Kuiper, George G. J. M., et al. “Estrogen Receptor β Selectivity of Estriol and Implications for Tissue-Specific Effects.” PNAS, vol. 94, no. 17, 1997, pp. 9105–9110. 15. Michnovicz, Joseph J., et al. “Dietary Indoles and Estrogen Metabolism: Effects of Cruciferous Vegetable Intake.” Journal of Nutrition, vol. 134, no. 12, 2004, pp. 3479S–   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

Pendant des années, le message a semblé simple : pour rester bien hydraté, il faut boire beaucoup d'eau. Pourtant, une vaste étude publiée dans le British Journal of Nutrition vient nuancer cette idée reçue. Menée sur près de 200 000 personnes dans plusieurs pays, cette recherche révèle que l'eau n'est pas le seul acteur de l'hydratation optimale. Thé, café et même certaines boissons lactées ou légèrement sucrées participeraient, eux aussi, à maintenir un bon équilibre hydrique et métabolique.L'étude s'est intéressée non seulement à la quantité de liquide absorbée, mais aussi à la manière dont le corps la retient. Car une hydratation efficace ne dépend pas uniquement du volume bu, mais de la capacité de l'organisme à conserver l'eau dans ses tissus. Or, le café et le thé, longtemps accusés d'être déshydratants à cause de leur caféine, se révèlent en réalité de bons contributeurs à l'équilibre hydrique, lorsqu'ils sont consommés avec modération. Les chercheurs ont montré qu'une à trois tasses par jour n'entraînent pas de perte d'eau significative, et peuvent même favoriser la vigilance, la concentration et la santé cardiovasculaire.Le secret réside dans la diversité des apports. L'eau reste indispensable, bien sûr : elle représente la base de l'hydratation. Mais les boissons contenant des minéraux, des antioxydants et un peu d'énergie (comme le lait, les infusions, ou le café léger) enrichissent ce bilan. Le lait, par exemple, grâce à sa teneur en sodium, potassium et protéines, offre un excellent pouvoir de réhydratation, supérieur à celui de l'eau seule après un effort. De même, les tisanes et thés verts, riches en polyphénols, aident à lutter contre l'oxydation cellulaire tout en hydratant efficacement.Les chercheurs rappellent aussi que l'alimentation joue un rôle crucial : les fruits et légumes, gorgés d'eau et d'électrolytes, représentent jusqu'à 20 % de nos apports hydriques quotidiens. Ainsi, une soupe, un yaourt ou une orange participent autant à l'hydratation qu'un grand verre d'eau.En conclusion, bien s'hydrater ne consiste pas à boire uniquement de l'eau à longueur de journée, mais à adopter une approche globale : varier les boissons, écouter sa soif et intégrer des aliments riches en eau. Le corps a besoin d'équilibre, pas d'excès. Et cette étude nous rappelle que la santé ne se joue pas seulement dans la quantité d'eau bue, mais dans l'harmonie subtile entre diversité, modération et plaisir. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Quattromila passi al giorno basterebbero alle donne over62 per proteggere il cuore ed essere più longeve. Questo è quanto sottolinea una ricerca pubblicata sul British Journal of Sports Medicine che commentiamo con il professor Claudio Borghi, direttore di Medicina Interna al Policlinico Sant'Orsola di Bologna.

Welcome back to the BJN podcast. In this episode, Sean Boyle (Editor, British Journal of Nursing) sits down with Caitlin Paterson (Drug Liaison Nurse) to discuss misconceptions relating to drug use, how drug use relates to the wider social healthcare issues, and how nurses can work with prevention measures.  The conversation explores Caitlin's experience working with this community, the truth behind common misconceptions about addiction and harm reduction, and what changes are needed in policy to prevent the UK from heading towards a US-style opioid crisis.  We're always keen to hear your feedback! If you'd like to share your thoughts on today's epsiode, drop us an email at: bjn@markallengroup.com  Like what you've heard here today? Check out the BJN website for more information on all things nursing: https://www.britishjournalofnursing.com/  The BJN podcast was edited by Tom Austin-Morgan: https://www.linkedin.com/in/thomasaustinmorgan/ 

Broadcast from KSQD, Santa Cruz on 10-23-2025: Dr. Dawn opens with a passionate plea about E-bike safety after observing riders ignoring stop signs and wearing inadequate helmets in Santa Cruz. She explains the physics of collisions, noting that force equals mass times acceleration, and a car hitting an E-bike rider at 20 mph delivers impact equivalent to falling from a two-story building. She emphasizes that 97% of bike fatalities in New York involved helmetless riders, and brain injuries result from the brain striking the skull twice during impact - once on the impact side and again on the opposite side during deceleration. She urges drivers to honk at helmetless riders and calls for stricter helmet law enforcement. An emailer asks about hydroxyapatite in toothpaste. Dr. Dawn traces its origins to NASA research in the 1960s by Dr. Bernard Rubin studying crystal growth for preventing bone and tooth mineral loss in astronauts. Japanese company Sangi acquired the patent and created the first hydroxyapatite toothpaste by 1980, receiving official anti-cavity recognition in 1993. Studies show it matches fluoride's cavity prevention effectiveness by filling microscopic cracks where bacteria take root. It also relieves temperature sensitivity by sealing micro-fractures in enamel that expose the dentin layer, making it especially helpful for people who clench their jaws. Researchers from UC Berkeley and the Allen Institute used electrodes and lasers to study how mouse brains process optical illusions like the Kanizsa triangle. They discovered specialized IC encoder neurons in the visual cortex that fill in missing information, creating complete shapes from partial cues. When these pattern-completing circuits activate inappropriately, they may trigger hallucinations in conditions like schizophrenia. Dr. Dawn explains that illusions occur when the brain perceives something different from actual visual input, while hallucinations create perceptions with no external stimulus. She discusses frontotemporal dementia where visual hallucinations result from protein deposits in the occipital cortex, and notes that a 2021 British Journal of Psychiatry study found hallucination rates varying from 7% in young people to 3% in those over 70. An emailer describes unbearable chronic lumbar pain with degenerative disc disease shown on MRI. Dr. Dawn emphasizes that MRI findings don't necessarily correlate with pain levels, citing shopping mall studies showing equal degenerative changes in people with and without back pain. She stresses checking for sciatica symptoms including leg pain below the knee, sensory differences between sides, calf size asymmetry, and ability to walk on tiptoes and heels. Without these red flags, the degenerative disease likely isn't causing the pain. She warns against unnecessary surgery citing frequent "failed back" syndrome when surgery for a disk image doesn't "fix" the pain. She recommends water jogging with a ski vest, McKenzie exercises, abdominal strengthening, ergonomics, removing wallets from back pockets, and alternating heat and ice therapy. She discusses mindfulness meditation and cognitive behavioral therapy for pain management. A caller references Daniel Levitin's book "Your Brain on Music," discussing research using functional MRIs showing distinct brain activation patterns in musicians versus non-musicians due to integrated auditory, visual, and kinesthetic training. Dr. Dawn describes how infant brains develop from three to six layers with increasingly complex synaptic connections resembling circuit boards. She highlights a blindfold study where college students' visual cortices began responding to sound within two weeks as the auditory cortex expanded. She shares her husband's remarkable recovery demonstrating adult brain plasticity through intensive rehabilitation. Learning new musical instruments helps dementia patients by activating multiple brain regions simultaneously and improving standard cognitive test performance. A caller describes an eight-day chest cold with thick white phlegm. Dr. Dawn recommends guaifenesin as a mucus-thinning expectorant to prevent bacterial growth in respiratory secretions that serve as "bacteria chow." She emphasizes the importance of current flu, COVID, and RSV vaccinations. Secondary bacterial infections develop when bacteria colonize viral-induced mucus in the lungs and invade tissues. She advises aggressive hydration and chicken soup, which research shows helps clear mucus. Another caller provides additional information about Daniel Levitin as a musicologist, neurologist, and musician who runs the Music Perception, Cognition and Expertise laboratory at McGill University.

Welcome back to the BJN podcast. In this episode, Sean Boyle (Editor, British Journal of Nursing) sits down with David Green (Nurse Consultant for Immunisation for the UK Health Security Agency) to discuss vaccination programmes and the nursing profession. The conversation explores vaccine scepticism in the UK, why David believes in the life-saving power of vaccines, and what needs to change in public attitudes and healthcare strategies to protect communities, both now and in the future. We're always keen to hear your feedback! If you'd like to share your thoughts on today's epsiode, drop us an email at: bjn@markallengroup.com  Like what you've heard here today? Check out the BJN website for more information on all things nursing: https://www.britishjournalofnursing.com/  The BJN podcast was edited by Tom Austin-Morgan: https://www.linkedin.com/in/thomasaustinmorgan/ 

Send us a text with your feedback from this session! Session 177 (World Congress - Dublin): Structural and Cultural Humility: A Concept and A MindsetGuests: Michael Cole and Tyrone Cassius Why do I believe what I believe? And, what do I do with what I believe? A critically reflective and meaningfully impactful discussion on the hidden curriculum of humanity within the Athletic Training and Therapy space. Michael Cole (he/they) graduated in 2001 as a Sports & Exercise Therapist and maintains a part-time private clinical practice in the UK, having previously worked in elite and grassroots sport, including with Team GB Swimming and in professional football. Previously Director and Chair of The Society of Sports Therapists, Michael currently works as a Board Trustee at NTDi, an industry consultant, and as the Principal Teaching Fellow in Equality, Diversity and Inclusion for the Undergraduate Primary Care Education Unit at Imperial College London. With over twenty years' experience, Michael has been awarded both a Principal Teaching Fellowship (PFHEA) and a National Teaching Fellowship (NTFS) and served multiple roles including as a BSc Sports Therapy course leader, an anti-racist pedagogy trainer, an external examiner and a national verifier. As part of his ongoing PhD research, Michael has authored several publications and founded the 'Cultural and Structural Humility in Europe Working Group' (CaSHEW). Contact Michael via email michael@aidfirst.co.uk or at www.linkedin.com/in/michael-c-4b7b84292Tyrone Cassius has spent the last 12 years, since graduating with a degree in Sports Therapy, immersing himself in the health & fitness industry, gaining experience pitch-side, in clinical case management and consultancy.His therapy work spans industries including football, theatre and private practice and he currently teaches at college and university level.As one of the Directors of the Society of Sports Therapists, he is involved in the structuring and governance of the profession. He chairs the Equality, Diversity & Inclusion team and works to highlight and implement many solutions to cultural and structural issues. Research includes the looking into the importance of cultural & structural humility within sport & exercise medicine and general healthcare.Contacts for Tyrone:Email: tyrone@specifeyehealth.comInstagram: t_cassh & specifeyehealthLinkedin: https://www.linkedin.com/in/tyrone-cassius-5140b54b?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=android_appHere are 3 links to the resources we mentioned on the pod:Inequalities across the physical activity landscape: the need for ‘structural humility' to optimise sports and exercise medicine | British Journal of Sports MedicineFrom Cultural Competency to Structural Humility | 18 | v2 | RoutledgeStructural Competency Working Group – Promoting the training of health professionals in structural competency around the country and beyond The World Federation of Athletic Training & Therapy is excited to announce the next International Athletic Training & Therapy Day on February 12th, 2026 (IATTD26)!Use: #IATTD26

Welcome back to the BJN podcast. In this episode, Sean Boyle (Editor, British Journal of Nursing) sits down with Luke Evans (Chair of the RCN Public Health Forum and a Registered Nurse Working in Health Equity) to discuss the nature of health inequalities and what can be done to address them. The conversation explores Luke's experiences in working to reduce disparities, why he believes in the power of nursing to make a difference, and what changes he thinks are needed, at both a local and national level, to create a fairer, healthier society for all.  We're always keen to hear your feedback! If you'd like to share your thoughts on today's epsiode, drop us an email at: bjn@markallengroup.com  Like what you've heard here today? Check out the BJN website for more information on all things nursing: https://www.britishjournalofnursing.com/  The BJN podcast was edited by Tom Austin-Morgan: https://www.linkedin.com/in/thomasaustinmorgan/ 

Social workers frequently come into contact with dogs in their practice. Yet until now, it hasn't featured in social work research, education, training and guidance.A recent study published in the British Journal of Social Work entitled ‘We're not professionals when it comes to dogs:' Social work encounters with dogs and their implications for education and practice sets out to address this omission. The research examines the risks and complexities that social workers might be faced with when encountering dogs, making a compelling case for greater attention on this subject area.In this episode, Jonny Adamson is joined by the author of the research, Professor Denise Turner, social worker Sarah Long, who participated in the study and experienced aggressive dog behaviour while on a visit, and Certified Animal Behaviourist, Andrew Hale who specialises in complex animal behaviour cases.They discuss how professionals can assess and minimise risk to themselves and others when encountering dogs, improvements and adjustments that employers could make to working practices, training and support needs for the profession, and the cultural, religious and health considerations which are being overlooked.Our thanks to James Ede at BeHeard for producing the episode. Hosted on Acast. See acast.com/privacy for more information.

Die Themen in den Wissensnachrichten: +++ Chemie-Nobelpreis für metallorganische Gerüste +++ Bewegungssnacks von fünf Minuten bringen was +++ Kakao gerade rar und teuer, bald wahrscheinlich umgekehrt +++**********Weiterführende Quellen zu dieser Folge:Chemie-Nobelpreis Pressemitteilung der Königlich-Schwedischen Akademie der Wissenschaften, 08.10.2025Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling in: Journal of Translational Medicine, 08.10.2025Effect of exercise snacks on fitness and cardiometabolic health in physically inactive individuals: systematic review and meta-analysis in: British Journal of Sports Medicine, 07.10.2025LIVE: Nobel Physics Laureate John Clarke Speaks at UC Berkeley | AQ1N, DRM News auf Youtube, 07.10.2025The walking moai hypothesis: Archaeological evidence, experimental validation, and response to critics, in: Journal of Archaeological Science, 11.2025Alle Quellen findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .

Send us a message with this link, we would love to hear from you. Standard message rates may apply. We unpack myths, the new stepwise approach, and why return to school should come before return to play.• what a concussion is• common and delayed symptoms including mood and sleep changes• immediate sideline steps• why “cocooning” is outdated and how light activity helps• individualized recovery timelines and risk of returning too soon• return-to-learn before return-to-play with simple accommodations• a staircase model for activity and symptom thresholds• helmets vs brain movement and the role of honest reporting• practical tips for coaches, parents, and student athletesCheck out our website, send us an email, share this with a friend or young student athlete who is playing some sports and might get a concussionReferencesBroglio SP, Register-Mihalik JK, Guskiewicz KM, et al. National Athletic Trainers' Association Bridge Statement: Management of Sport-Related Concussion. Journal of Athletic Training. 2024;59(3):225-242. doi:10.4085/1062-6050-0046.22.Centers for Disease Control and Prevention Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children. Lumba-Brown A, Yeates KO, Sarmiento K, et al. JAMA Pediatrics. 2018;172(11):e182853. doi:10.1001/jamapediatrics.2018.2853.Feiss R, Lutz M, Reiche E, Moody J, Pangelinan M. A Systematic Review of the Effectiveness of Concussion Education Programs for Coaches and Parents of Youth Athletes. International Journal of Environmental Research and Public Health. 2020;17(8):E2665. doi:10.3390/ijerph17082665.Gereige RS, Gross T, Jastaniah E. Individual Medical Emergencies Occurring at School. Pediatrics. 2022;150(1):e2022057987. doi:10.1542/peds.2022-057987.Giza CC, Kutcher JS, Ashwal S, et al. Summary of Evidence-Based Guideline Update: Evaluation and Management of Concussion in Sports: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80(24):2250-2257. doi:10.1212/WNL.0b013e31828d57dd.Halstead ME. What's New With Pediatric Sport Concussions? Pediatrics. 2024;153(1):e2023063881. doi:10.1542/peds.2023-063881.Halstead ME, Walter KD, Moffatt K. Sport-Related Concussion in Children and Adolescents. Pediatrics. 2018;142(6):e20183074. doi:10.1542/peds.2018-3074.Leddy JJ. Sport-Related Concussion. The New England Journal of Medicine. 2025;392(5):483-493. doi:10.1056/NEJMcp2400691.McCrea M, Broglio S, McAllister T, et al. Return to Play and Risk of Repeat Concussion in Collegiate Football Players: Comparative Analysis From the NCAA Concussion Study (1999–2001) and CARE Consortium (2014–2017). British Journal of Sports Medicine. 2020;54(2):102-109. doi:10.1136/bjsports-2019-100579.Scorza KA, Cole W. Current Concepts in Concussion: Initial Evaluation and Management. American Family Physician. 2019;99(7):426-434.Shirley E, Hudspeth LJ, Maynard JR. Managing Sports-Related Concussions From Time of Injury Through Return to Play. The Journal of the American Academy of Orthopaedic Surgeons. 2018;26(13):e279-e286. doi:10.5435/JAAOS-D-16-00684.Zhou H, Ledsky R, Sarmiento K, et al. Parent-Child Communication About ConcussSupport the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Tagträumen ist, wenn wir abschweifen und mit unseren Gedanken irgendwo hängenbleiben. Es kann Kreativität, aber auch Ängste befördern. Was dabei im Gehirn passiert, und was es mit uns macht, darum geht es diese Woche in Achtsam.**********An dieser Stelle findet ihr die Übung:25:23:00 - Übung: Geleitete Meditation**********Quellen aus der Folge:McMillan, R., Kaufman, S. B., & Singer, J. L. (2013). Ode to positive constructive daydreaming. Frontiers in psychology, 4, 60812. Soffer-Dudek, N., Somer, E., Spiegel, D., Chefetz, R., O'Neil, J., Dorahy, M. J., ... & Middleton, W. (2025). Maladaptive daydreaming should be included as a dissociative disorder in psychiatric manuals: position paper. The British Journal of Psychiatry, 226(4), 238-242. Killingsworth, M. A., & Gilbert, D. T. (2010). A wandering mind is an unhappy mind. Science, 330(6006), 932-932. Zhiyan, T., & Singer, J. L. (1997). Daydreaming styles, emotionality and the big five personality dimensions. Imagination, Cognition and Personality, 16(4), 399-414. **********Mehr zum Thema bei Deutschlandfunk Nova:Arbeit mit den Anteilen: Das steckt hinter der SchematherapieDas Gefühl, wichtig zu sein: Mattering ist für unser Wohlbefinden essenziellTod, Sinn und Schmerz: Die existenzielle Psychotherapie**********Den Artikel zum Stück findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .**********Ihr habt Anregungen, Ideen, Themenwünsche? Dann schreibt uns gern unter achtsam@deutschlandfunknova.de

This show has been flagged as Explicit by the host. Quick-Glance Summary I walk you through an MIT experiment where 54 EEG-capped volunteers wrote essays three ways: pure brainpower, classic search, and ChatGPT assistance. Brain-only writers lit up the most neurons and produced the freshest prose; the ChatGPT crowd churned out near-identical essays, remembered little, and racked up what the researchers dub cognitive debt : the interest you pay later for outsourcing thought today. A bonus “switch” round yanked AI away from the LLM devotees (cue face-plant) and finally let the brain-first team play with the toy (they coped fine), proving skills first, tools second. I spiced the tale with calculator nostalgia, a Belgian med-exam cheating fiasco, and Professor Felienne's forklift-in-the-gym metaphor to land one mantra: *scaffolds beat shortcuts*. We peeked at tech “enshittification” once investors demand returns, whispered “open-source” as the escape hatch, and I dared you to try a two-day test—outline solo, draft with AI, revise solo, then check what you still remember. Net takeaway: keep AI on a leash; let thinking drive, tools navigate . If you think I'm full of digital hot air, record your own rebuttal and prove it. Resources MIT study MIT Media Lab. (2025). Your brain on ChatGPT: Accumulation of cognitive debt. https://www.media.mit.edu/publications/your-brain-on-chatgpt/ Long term consequences (to be honest - pulled these from another list, didn't check all of them) Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Herrero-Roldán, S., Rodriguez-Besteiro, S., Martínez-Guardado, I., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2024). Digital device usage and childhood cognitive development: Exploring effects on cognitive abilities. Children , 11(11), 1299. https://pmc.ncbi.nlm.nih.gov/articles/PMC11592547/ Grinschgl, S., Papenmeier, F., & Meyerhoff, H. S. (2021). Consequences of cognitive offloading: Boosting performance but diminishing memory. Quarterly Journal of Experimental Psychology , 74(9), 1477–1496. https://pmc.ncbi.nlm.nih.gov/articles/PMC8358584/ Ward, A. F., Duke, K., Gneezy, A., & Bos, M. W. (2017). Brain drain: The mere presence of one's own smartphone reduces available cognitive capacity. Journal of the Association for Consumer Research , 2(2), 140–154. https://www.journals.uchicago.edu/doi/full/10.1086/691462 Zhang, M., Zhang, X., Wang, H., & Yu, L. (2024). Understanding the influence of digital technology on cognitive development in children. Current Research in Behavioral Sciences , 5, 100224. https://www.sciencedirect.com/science/article/pii/S266724212400099X Risko, E. F., & Dunn, T. L. (2020). Developmental origins of cognitive offloading. Developmental Review , 57, 100921. https://pubmed.ncbi.nlm.nih.gov/32517613/ Ladouceur, R. (2022). Cognitive effects of prolonged continuous human-machine interactions: Implications for digital device users. Behavioral Sciences , 12(8), 240. https://pmc.ncbi.nlm.nih.gov/articles/PMC10790890/ Wong, M. Y., Yin, Z., Kwan, S. C., & Chua, S. E. (2024). Understanding digital dementia and cognitive impact in children and adolescents. Neuroscience Bulletin , 40(7), 628–635. https://pmc.ncbi.nlm.nih.gov/articles/PMC11499077/ Baxter, B. (2025, February 2). Designing AI for human expertise: Preventing cognitive shortcuts. UXmatters . https://www.uxmatters.com/mt/archives/2025/02/designing-ai-for-human-expertise-preventing-cognitive-shortcuts.php Tristan, C., & Thomas, M. (2024). The brain digitalization: It's all happening so fast! Frontiers in Human Dynamics , 4, 1475438. https://www.frontiersin.org/journals/human-dynamics/articles/10.3389/fhumd.2024.1475438/full Sun, Z., & Wang, Y. (2024). Two distinct neural pathways for mechanical versus digital memory aids. NeuroImage , 121, 117245. https://www.sciencedirect.com/science/article/pii/S1053811924004683 Ahmed, S. (2025). Demystifying the new dilemma of brain rot in the digital era. Contemporary Neurology , 19(3), 241–254. https://pmc.ncbi.nlm.nih.gov/articles/PMC11939997/ Redshaw, J., & Adlam, A. (2020). The nature and development of cognitive offloading in children. Child Development Perspectives , 14(2), 120–126. https://srcd.onlinelibrary.wiley.com/doi/10.1111/cdep.12532 Geneva Internet Platform. (2025, June 3). Cognitive offloading and the future of the mind in the AI age. https://dig.watch/updates/cognitive-offloading-and-the-future-of-the-mind-in-the-ai-age Karlsson, G. (2019). Reducing cognitive load on the working memory by externalizing information. DIVA Portal . http://www.diva-portal.org/smash/get/diva2:1327786/FULLTEXT02.pdf Monitask. (2025). What is cognitive offloading? https://www.monitask.com/en/business-glossary/cognitive-offloading Sharma, A., & Watson, S. (2024). Human technology intermediation to reduce cognitive load. Journal of the American Medical Informatics Association , 31(4), 832–841. https://academic.oup.com/jamia/article/31/4/832/7595629 Morgan, P. L., & Risko, E. F. (2021). Re-examining cognitive load measures in real-world learning environments. British Journal of Educational Psychology , 91(3), 993–1013. https://bpspsychub.onlinelibrary.wiley.com/doi/10.1111/bjep.12729 Podcast episodes that inspired some thoughts Felien Hermans (NL) Tech won't save us Screenstrong Families Provide feedback on this episode.

Michael Rectenwald discusses his newly founded Anti-Zionist America PAC (AZAPAC) which exists to end America's political, financial, and military entanglement with Israel. He explains what has gone wrong with Zionist influence, how its mask has come off under the Trump administration, the attack on civil liberties, the devastation of Gaza, and more. He also gives an update on where we're at with the globalist project for a technocratic world state. Watch on BitChute / Brighteon / Rumble / Substack / YouTube Geopolitics & Empire · Michael Rectenwald: Disentangling the Zionist Lobby Through AZAPAC #572 *Support Geopolitics & Empire! Become a Member https://geopoliticsandempire.substack.com Donate https://geopoliticsandempire.com/donations Consult https://geopoliticsandempire.com/consultation **Visit Our Affiliates & Sponsors! Above Phone https://abovephone.com/?above=geopolitics easyDNS (15% off with GEOPOLITICS) https://easydns.com Escape The Technocracy (15% off with GEOPOLITICS) https://escapethetechnocracy.com/geopolitics Expat Money Summit 2025 (20% off VIP with EMPIRE) https://2025.expatmoneysummit.com PassVult https://passvult.com Sociatates Civis https://societates-civis.com StartMail https://www.startmail.com/partner/?ref=ngu4nzr Wise Wolf Gold https://www.wolfpack.gold/?ref=geopolitics Websites Michael Rectenwald https://www.michaelrectenwald.com AZAPAC https://www.aza-pac.com Substack https://mrectenwald.substack.com X https://x.com/RecTheRegime About Michael Rectenwald Dr. Michael Rectenwald is the author of twelve books, including The Great Reset and the Struggle for Liberty: Unraveling the Global Agenda (Jan. 2023), Thought Criminal (Dec. 2020); Beyond Woke (May 2020); Google Archipelago: The Digital Gulag and the Simulation of Freedom (Sept. 2019); Springtime for Snowflakes: “Social Justice” and Its Postmodern Parentage (an academic's memoir, 2018); Nineteenth-Century British Secularism: Science, Religion and Literature (2016); Academic Writing, Real World Topics (2015, Concise Edition 2016); Global Secularisms in a Post-Secular Age (2015); Breach (Collected Poems, 2013); The Thief and Other Stories (2013); and The Eros of the Baby-Boom Eras (1991). (See the Books page.) Michael was a distinguished fellow at Hillsdale College and a Professor of Liberal Studies and Global Liberal Studies at NYU. He also taught at Duke University, North Carolina Central University, Carnegie Mellon University, and Case Western Reserve University. His scholarly and academic essays have appeared in The Quarterly Journal of Austrian Economics, Academic Questions, Endeavour, The British Journal for the History of Science, College Composition and Communication, International Philosophical Quarterly, the De Gruyter anthologies Organized Secularism in the United States and Global Secularisms in a Post-Secular Age, and the Cambridge University Press anthology George Eliot in Context, among others (see the Academic Scholarship page). He holds a Ph.D. in Literary and Cultural Studies from Carnegie Mellon University, a Master's in English Literature from Case Western Reserve University, and a B.A. in English Literature from the University of Pittsburgh. (See his C.V. for details.) Michael's writing for general audiences has appeared on The Mises Institute Wire, Newsweek, The Epoch Times, RT.com, Campus Reform, The New English Review, The International Business Times, The American Conservative, Quillette, The Washington Post, Pittsburgh Post-Gazette, CLG News, LotusEaters.com, Chronicles, and others. (See the Essays and Presentations page.) Michael has appeared on major network political talk shows (Tucker Carlson Tonight, Tucker Carlson Originals, Fox & Friends, Fox & Friends First, Varney & Company, The Ingraham Angle, Unfiltered with Dan Bongino, The Glenn Beck Show), on syndicated radio shows (Coast to Coast AM, Glenn Beck, The Larry Elder Show, and many others),

Here we have the long-awaited conclusion to our epic series on the saga of HMCS Karluk Don't forget that there is a bonus Part V available for patrons, covering Stefansson's later ill-fated attempt at colonizing Wrangel IslandMajor thanks to Jess (@jesslovesboats) for guiding us through this story! gazafunds.comSources:Cavell, Janice. “The Karluk's Lost Men: The Alexander Anderson and Alister Forbes Mackay Parties, 1914.” The Journal of the Hakluyt Society, March 2025, pp. 1 - 31. Diubaldo, Richard J. Stefansson and the Canadian Arctic. McGill-Queen's University Press, 1978.Jenness, Stuart E. Stefansson, Dr. Anderson, and the Canadian Arctic Expedition, 1913-1918: A Story of Exploration, Science and Sovereignty. Canadian Museum of Civilization Corporation, 2011.Levere, Trevor H. “Vilhjalmur Stefansson, the Continental Shelf, and a New Arctic Continent.” The British Journal for the History of Science, vol. 21, no. 2, June 1988, pp. 233 - 247. Levy, Buddy. Empire of Ice and Stone: The Disastrous and Heroic Voyage of the Karluk. St Martin's Press, 2022. Niven, Jennifer. The Ice Master: The Doomed 1913 Voyage of the Karluk. Hyperion, 2000.Sowards, Adam M. “Claiming Spaces for Science.” Historical Studies in the Natural Sciences, vol. 47, no. 2, Apr 2017, pp. 164 - 199. Stefansson, Vilhjalmur. The Friendly Arctic. Macmillan, 1921. www.loc.gov/item/21021129/Stefansson, Vilhjalmur. “Letter from Mr. Stefansson.” The Geographical Journal, vol. 52, no. 4, Oct 1918, pp. 248 - 255. Stefansson, Vilhjalmur. “‘Living Off the Country' as a Method of Arctic Exploration.” Geographical Review, vol. 7, no. 5, May 1919, pp. 291 - 310. Stefansson, Vilhjalmur. “Plover Land and Borden Land.” Geographic Review, vol. 11, no. 2, Apr 1921, pp. 283 - 291. Stefansson, Vilhjalmur. “Stefansson's Expedition.” Bulletin of the American Geographical Society, vol. 46, no. 3, 1914, pp. 184 - 191. UPI. “North Pole fuss just Peary's word against Cook's now.” https://www.upi.com/Archives/1909/09/10/Pole-fuss-just-Pearys-word-against-Cooks-now/3310181788478/Webb, Melody. “Arctic Saga: Vilhjalmur Stefansson's Attempt to Colonize Wrangel Island.” Pacific Historical Review, vol. 61, no. 2, May 1992, pp. 215 - 239. Support the show

ENCORE: This episode was first published in Oct. 2023. Sierra Leone used to be the most dangerous place in the world to give birth. Without enough doctors to do C-sections, women and babies were dying. But what if you didn't need a doctor?This week, the story of two determined surgeons and a no-so radical idea that is saving lives in Sierra Leone — one emergency operation at a time.You can read more about the non-profit organization the doctors created at capacare.orgOur guests on the show are Håkon Bolkan, Alex van Duinen and Emmanuel Tommy. You can download the episode transcript here:Here are some of the articles discussed in the show:Bolkan, HA et al. (2015) Met and unmet need for surgery in Sierra Leone: a comprehensive retrospective countrywide survey from all healthcare facilities performing surgery in 2012. SurgeryBrolin, K et al. (2016) The Impact of the West Africa Ebola Outbreak on Obstetric Health Care in Sierra Leone. PLOS ONEBolkan, HA et al.. (2017) Safety, productivity and predicted contribution of a surgical task-sharing programme in Sierra Leone. British Journal of SurgeryTreacy, Laura; Bolkan, Håkon Angell; Sagbakken, Mette. (2018) Distance, accessibility and costs. Decision-making During Childbirth in Rural Sierra Leone: a Qualitative Study. PLOS ONEDrevin, Gustaf; Alvesson, Helle Mölsted; van Duinen, Aalke Johan; Bolkan, Håkon Angell; Koroma, Alimamy philip; von Schreeb, Johan. (2019) ”For this one, let me take the risk”: why surgical staff continued to perform caesarean sections during the 2014–2016 Ebola epidemic in Sierra Leone. BMJ Global Healthvan Duinen, Aalke Johan; Kamara, Michael M.; Hagander, Lars; Ashley, Thomas; Koroma, Alimamy Philip; Leather, Andy J.M.. (2019) Caesarean section performed by medical doctors and associate clinicians in Sierra Leone. British Journal of Surgeryvan Duinen, Aalke Johan; Westendorp, Josien; Kamara, Michael M; Forna, Fatu; Hagander, Lars; Rijken, Marcus J.. (2020) Perinatal outcomes of cesarean deliveries in Sierra Leone: A prospective multicenter observational study. International Journal of Gynecology & Obstetrics Hosted on Acast. See acast.com/privacy for more information.

Why are we still treating acute uncomplicated diverticulitis with antibiotics? There is plenty of evidence from several randomized controlled trials demonstrating that symptomatic management alone yields similar results. If we should continue prescribing antibiotics for acute uncomplicated diverticulitis, which patients should undergo treatment and when? Join Drs. Jared Hendren, Elissa Dabaghi, Joseph Trunzo, Ajaratu Keshinro, and David Rosen as they discuss the management of uncomplicated diverticulitis while reviewing groundbreaking literature. Hosts: -Jared Hendren, MD Institution: Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio - Elissa Dabaghi, MD Institution: Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio - Joseph Trunzo, MD Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio Social Media Handle: X/Twitter @joseph_trunzo - Ajaratu Keshinro, MD Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio Social Media Handle: X/Twitter- @AJKesh - David Rosen, MD Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio Social Media Handle: X/Twitter- @davidrrosenmd Learning Objectives: By the end of this episode, listeners will be able to: 1.     Identify criteria for managing acute uncomplicated diverticulitis without antibiotics based on recent literature 2.     Define uncomplicated and complicated diverticulitis 3.     Discuss nuanced management decisions of patients with uncomplicated diverticulitis to determine when antibiotics may be appropriate for management References: 1.     Azhar, N., Aref, H., Brorsson, A., Lydrup, M.‑L., Jörgren, F., Schultz, J. K., & Buchwald, P. (2022). Management of acute uncomplicated diverticulitis without antibiotics: Compliance and outcomes – a retrospective cohort study. BMC Emergency Medicine, 22(1), Article 28. https://doi.org/10.1186/s12873‑022‑00584‑X  2.     Mora‑López, L., Ruiz‑Edo, N., Estrada‑Ferrer, O., Piñana‑Campón, M. L., Labró‑Ciurans, M., Escuder‑Perez, J., Sales‑Mallafré, R., Rebasa‑Cladera, P., Navarro‑Soto, S., Serra‑Aracil, X., & DINAMO‑study Group. (2021). Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO‑study): A multicentre, randomised, open‑label, noninferiority trial. Annals of Surgery, 274(5), e435–e442. https://doi.org/10.1097/SLA.0000000000005031 3.     Daniels, L., Ünlü, Ç., de Korte, N., van Dieren, S., Stockmann, H. B., Vrouenraets, B. C., Consten, E. C., van der Hoeven, J. A., Eijsbouts, Q. A., Faneyte, I. F., Bemelman, W. A., Dijkgraaf, M. G., & Boermeester, M. A. (2017). Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT‑proven uncomplicated acute diverticulitis. British Journal of Surgery, 104(1), 52‑61. https://doi.org/10.1002/bjs.10309 4.     Chabok, A., Påhlman, L., Hjern, F., Haapaniemi, S., & Smedh, K.; AVOD Study Group. (2012). Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. British Journal of Surgery, 99(4), 532–539. https://doi.org/10.1002/bjs.8688 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

A UK study has suggested that the wordier your apology, the more effective it is.The British Journal of Psychology has said that if you want to truly convince people that you are sorry, then longer words make you sound more sincere.Do you agree?Joining Andrea to discuss is Leslie Shoemaker, Counselling Psychologist and Lecturer in TU Dublin and Mary McCarthy, Irish Independent Columnist.

Jess (@jesslovesboats) is back to navigate us through Part Three (of Four) in the saga of the Karluk!gazafunds.comSources for Part II:Cavell, Janice. "The Karluk's Lost Men: The Alexander Anderson and Alister Forbes Mackay Parties, 1914." The Journal of the Hakluyt Society, March 2025, pp. 1 - 31. Diubaldo, Richard J. Stefansson and the Canadian Arctic. McGill-Queen's University Press, 1978.Levere, Trevor H. “Vilhjalmur Stefansson, the Continental Shelf, and a New Arctic Continent.” The British Journal for the History of Science, vol. 21, no. 2, June 1988, pp. 233 - 247. Levy, Buddy. Empire of Ice and Stone: The Disastrous and Heroic Voyage of the Karluk. St Martin's Press, 2022. Niven, Jennifer. The Ice Master: The Doomed 1913 Voyage of the Karluk. Hyperion, 2000.Stefansson, Vilhjalmur. The Friendly Arctic. Macmillan, 1921. www.loc.gov/item/21021129/Stefansson, Vilhjalmur. “Letter from Mr. Stefansson.” The Geographical Journal, vol. 52, no. 4, Oct 1918, pp. 248 - 255. Stefansson, Vilhjalmur. “‘Living Off the Country' as a Method of Arctic Exploration.” Geographical Review, vol. 7, no. 5, May 1919, pp. 291 - 310. Stefansson, Vilhjalmur. “Stefansson's Expedition.” Bulletin of the American Geographical Society, vol. 46, no. 3, 1914, pp. 184 - 191. Support the show

Clark and Matt decided to share a special episode from our sister cast, YOU OUGHTA KNOW: THE MOTIVATION SERIES. In this special episode, Matt is joined by the co-developer of Self-Determination Theory (SDT), Richard M. Ryan, to talk about all things motivation. Think of it as a primer on SDT. We hit the basics… What is motivation? What is SDT?‎ ‎What are the origins of SDT?‎ ‎The different types of motivation.‎ ‎Rewards and their impact on one's motivation.‎ ‎Of course, the famous three basic psychological needs (autonomy, competence, and relatedness).‎ ‎We discuss strategies one may take to either create environments to meet others' needs or to do it for oneself.‎ ‎What is well-being? How is well-being related to motivation?‎ ‎Is SDT universal? Is it culturally descriptive in all cases?‎ ‎And more! During our discussion on mindfulness, Rich refers to a recently published meta-analysis.  The reference is: Donald, James N., Helena Nguyen, James H. Conigrave, Anya Johnson, Inmaculada Adarves-Yorno, Ryan Cheng, Anya Bedi, Kevin B. Lowe, Jessica L. Lyons, Emma K. Devine, Georg B. Tamm and Richard M. Ryan (2025). ‘ Does Leaders' Mindfulness Benefit Followers? A Meta-analytic Review and Research Agenda.' British Journal of Management, 11111. https://doi.org/10.1111/1467-8551.70009  Matt refers to a 1999 meta-analysis on the impact of rewards. That reference is: Deci, E. L., Koestner, R., & Ryan, R. M. (1999). A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychological Bulletin, 125(6), 627–668. https://doi.org/10.1037/0033-2909.125.6.627 Three references about the cultural generalizability of SDT are: Chirkov, V., Ryan, R. M., Kim, Y., & Kaplan, U. (2003). Differentiating autonomy from individualism and independence: A self-determination theory perspective on internalization of cultural orientations and well-being. Journal of Personality and Social Psychology, 84(1), 97–110. https://doi.org/10.1037/0022-3514.84.1.97 Chirkov, V. I. (2009). A cross-cultural analysis of autonomy in education: A self-determination theory perspective. Theory and Research in Education, 7, 253-262. https://doi.org/ Chirkov, V. I. (2017). Culture and autonomy. The Praeger handbook of personality across cultures, 2, 91-119. https://doi.org/ Rich is a clinical psychologist and is currently a Professorial Fellow at the Australian Catholic University's Institute for Positive Psychology & Education in North Sydney; he's also Professor Emeritus of Psychology at the University of Rochester, where he helped spark one of the most enduring frameworks of human motivation in the last half-century. 

Are ultrarunners at higher risk of colon cancer? Can scrolling before a workout actually make you slower? And is muscle damage( not gut issues) the biggest reason athletes DNF ultras? This episode dives deep into three new studies that every endurance athlete should know about.Zoë and TJ break down the recent New York Times article on colon cancer risk in marathoners and ultrarunners, explaining why the headlines caused panic, what the data really says, and how to think critically about risk. They then discuss surprising new evidence that social media use before training may blunt your skill development and endurance. Finally, they dig into a groundbreaking study on muscle damage in ultras, why durability may matter more than VO₂max, and practical training strategies to keep your legs from blowing up on race day.Scroll to the bottom to see our citations for this episode!⏱️ TIMESTAMPS00:00 – Intro + Run Rabbit taper talk09:42 – Colon cancer study explained28:50 – Social media and mental fatigue in athletes42:00 – Muscle damage vs. GI distress in ultras01:20:15 – Practical training takeaways

Jess is back as we get further into the saga of the Karluk (emphasis on the second syllable). If you've been waiting for the shipwreck, wait no more!Sources for Part II:Cavell, Janice. "The Karluk's Lost Men: The Alexander Anderson and Alister Forbes Mackay Parties, 1914." The Journal of the Hakluyt Society, March 2025, pp. 1 - 31. Diubaldo, Richard J. Stefansson and the Canadian Arctic. McGill-Queen's University Press, 1978.Levere, Trevor H. “Vilhjalmur Stefansson, the Continental Shelf, and a New Arctic Continent.” The British Journal for the History of Science, vol. 21, no. 2, June 1988, pp. 233 - 247. Levy, Buddy. Empire of Ice and Stone: The Disastrous and Heroic Voyage of the Karluk. St Martin's Press, 2022. Niven, Jennifer. The Ice Master: The Doomed 1913 Voyage of the Karluk. Hyperion, 2000.Stefansson, Vilhjalmur. The Friendly Arctic. Macmillan, 1921. www.loc.gov/item/21021129/Stefansson, Vilhjalmur. “Letter from Mr. Stefansson.” The Geographical Journal, vol. 52, no. 4, Oct 1918, pp. 248 - 255. Stefansson, Vilhjalmur. “‘Living Off the Country' as a Method of Arctic Exploration.” Geographical Review, vol. 7, no. 5, May 1919, pp. 291 - 310. Stefansson, Vilhjalmur. “Stefansson's Expedition.” Bulletin of the American Geographical Society, vol. 46, no. 3, 1914, pp. 184 - 191. Support the show

Welcome to the Social-Engineer Podcast: The Doctor Is In Series – where we will discuss understandings and developments in the field of psychology.   In today's episode, Chris and Abbie delve into the fascinating world of intuition and gut feelings. They explore whether these instincts are rooted in biology or shaped by past experiences and discuss the science behind how our brains process environmental cues to make quick decisions. [Sept 1, 2025]   00:00 - Intro 00:44 - Dr. Abbie Maroño Intro 01:02 - Intro Links -          Social-Engineer.com - http://www.social-engineer.com/ -          Managed Voice Phishing - https://www.social-engineer.com/services/vishing-service/ -          Managed Email Phishing - https://www.social-engineer.com/services/se-phishing-service/ -          Adversarial Simulations - https://www.social-engineer.com/services/social-engineering-penetration-test/ -          Social-Engineer channel on SLACK - https://social-engineering-hq.slack.com/ssb -          CLUTCH - http://www.pro-rock.com/ -          innocentlivesfoundation.org - http://www.innocentlivesfoundation.org/                                 02:23 - New Book Announcement -          Lilly the Brave Lion - Dr. Abbie Maroño 03:34 - The Topic of the Day: All About Intuition 06:04 - Is Intuition Always Right? 10:39 - Training Over Instinct 13:56 - Teaching Autonomy 16:39 - Facing Hard Truths 20:19 - Lack of Self Trust 24:06 - Intuition or Trauma Response? 26:16 - Wrap Up & Outro -          www.social-engineer.com -          www.innocentlivesfoundation.org   Find us online: -          LinkedIn: linkedin.com/in/dr-abbie-maroño-phd -          Instagram: @DoctorAbbieofficial -          LinkedIn: linkedin.com/in/christopherhadnagy     References: American Psychological Association. (n.d.). Intuition. In APA Dictionary of Psychology. Retrieved March 29, 2025, from https://dictionary.apa.org/intuition   Bechara, A., Damasio, H., Tranel, D., & Damasio, A. R. (1997). Deciding advantageously before knowing the advantageous strategy. Science, 275(5304), 1293–1295. https://doi.org/10.1126/science.275.5304.1293   Dane, E., & Pratt, M. G. (2007). Exploring intuition and its role in managerial decision making. Academy of Management Review, 32(1), 33–54. https://doi.org/10.5465/amr.2007.23463682   Gigerenzer, G. (2007). Gut feelings: The intelligence of the unconscious. Viking.   Hodgkinson, G. P., Langan-Fox, J., & Sadler-Smith, E. (2008). Intuition: A fundamental bridging construct in the behavioral sciences. British Journal of Psychology, 99(1), 1–27. https://doi.org/10.1348/000712607X216666   Kahneman, D. (2011). Thinking, fast and slow. Farrar, Straus and Giroux.   Lieberman, M. D. (2000). Intuition: A social cognitive neuroscience approach. Psychological Bulletin, 126(1), 109–137. https://doi.org/10.1037/0033-2909.126.1.109   Sadler-Smith, E., & Shefy, E. (2004). The intuitive executive: Understanding and applying 'gut feel' in decision-making. Academy of Management Executive, 18(4), 76–91. https://doi.org/10.5465/ame.2004.15268692

Dr Azra Raza is a Professor of Medicine, Clinical Director of the Evans Foundation MDS Center, and Executive Director of The First Cell Coalition for Cancer Survivors at Columbia University in New York. She is the best-selling author of "The First Cell: And the human costs of pursuing cancer to the last". She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010. Before moving to New York, Dr Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards.TIMESTAMPS:(0:00) - Introduction (0:50) - The First Cell: and the human costs of pursuing cancer to the last(4:10) - Defining Cancer(7:50) - A Cancer Paradigm Shift: Finding the First Cell(11:16) - "The Cure for Cancer"(19:05) - Azra's Journey, Development & Reception(24:40) - Hope, Honesty & Harm in a Clinical Setting(33:00) - Current Medical Politics vs Revolutionary Detections/Treatments(39:00) - Increasing Lifespan & Healthspan(43:01) - "Michael Levin Should Win The Nobel Prize!"(51:00) - A Good Life & a Good Death(56:00) - How Words distort our relationship with Disease(1:00:00) - How Disease & Death Shape Our Lives(1:05:40) - The First Cell Book(1:09:15) - A Better Healthcare System(1:12:27) - Conclusion EPISODE LINKS:- Azra's Website: https://azraraza.com- Azra's Books: https://azraraza.com/books- Azra's X: https://x.com/AzraRazaMD- Azra's YouTube: http://www.youtube.com/@AzraRazaMDCONNECT:- Website: https://tevinnaidu.com - Podcast: https://creators.spotify.com/pod/show/mindbodysolution- YouTube: https://youtube.com/mindbodysolution- Twitter: https://twitter.com/drtevinnaidu- Facebook: https://facebook.com/drtevinnaidu - Instagram: https://instagram.com/drtevinnaidu- LinkedIn: https://linkedin.com/in/drtevinnaidu=============================Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

Standing on stage with nothing but a microphone, Sara Pascoe knows instantly if she's succeeded or failed. Comedy doesn't let you hide, if the joke doesn't land, the silence tells you.But what makes Sara remarkable isn't just her success as a writer, actor, and stand-up. It's the habit she's built to handle failure and keep showing up: Unconditional Positive Regard. The belief that your worth isn't defined by a single mistake, a bad night, or a difficult moment.In this episode, I share what I learned from Sara about how self-compassion fuels resilience. She shows us why the way we talk to ourselves matters more than the outcome, and how reframing failure can turn doubt into progress.Together, we explore:Why comedians face some of the toughest performance pressureHow to separate who you are from what you doThe psychology of Unconditional Positive RegardHow self-compassion creates lasting confidenceIf you've ever been too hard on yourself after falling short, this episode is a reminder that high performance isn't about being flawless. It's about having the courage to try again, and the kindness to believe in yourself when you do.Here is more information on the studies referenced: The necessary and sufficient conditions of therapeutic personality change. Journal of Consulting Psychology (Rogers, C. R. 1957)Perceived Coach Empathy and Athlete Outcomes International Journal of Environmental Research and Public Health (2023)Alex Shevrin: Unconditional Positive Regard Video, Massachusetts Teachers Association.Bringing Carl Rogers Back In: Exploring the Power of Positive Regard at Work, British Journal of Management, 2018Listen to the full episode with Sara Pascoe: https://pod.fo/e/2b7c84 Hosted on Acast. See acast.com/privacy for more information.

Welcome to Season 14 Episode 31 of the ParentingAces Podcast! In this week's episode, Dr. Mark Kovacs is back to dive deeper into a recent social media post about the decreased fitness levels he's seeing in junior tennis players and what we can do to help our players get fit and stay injury-free.In case you're unsure as to why you should pay attention to what Mark has to say, he is a renowned performance physiologist, researcher, university professor, author, speaker and coach with an extensive background training and researching athletes at all levels. He serves the iTPA membership as its Executive Director. He formally directed the Sport Science, Strength & Conditioning and Coaching Education departments for USTA. He is a Fellow of the American College of Sports Medicine and the ITPA. He has published over 50 peer-reviewed scientific articles and abstracts in top journals including the British Journal of Sports Medicine, Sports Medicine, Sports Health, International Journal of Sport Physiology and Performance, Strength & Conditioning Journal, Journal of Sports Science and Medicine among many others. He has presented workshops and keynote addresses on four continents and well over 100 presentations. Along with his academic and scientific background Dr. Kovacs is also a coach and former professional athlete. He was an All-American and NCAA doubles champion in tennis at Auburn University. After playing professionally, he completed his graduate work at Auburn University and earned his Ph.D. in Exercise Physiology from The University of Alabama. Dr. Kovacs is a Certified Strength and Conditioning Specialist through the National Strength and Conditioning Association, a certified Health/Fitness Specialist through the American College of Sports Medicine, a United States Track and Field Level II Sprints Coach and Certified Tennis Coach. This man has the bona fides!You'll hear Mark discuss the Gatorade Sweat Patch as an easy tool to measure sweat level. You can get more information and order them through the Gatorade website at https://www.gatorade.com/equipment/gx-sweat-patch/gx-sweat-patch-00052000048520. Mark and I also discuss his recent article on combating jet lag which you can find here: Click HereTo reach out to Mark directly, email him at mark@kovacsinstitute.com. You can also follow him on Instagram at https://instagram.com/drmarkkovacs. To find our podcast on periodization, go to https://parentingaces.com/podcasts/what-is-periodization-how-do-we-use-it-with-dr-mark-kovacs/.As always, I am available for one-to-one consults to work with you as you find your way through the college recruiting process. You can purchase and book online through our website at ⁠⁠⁠⁠⁠⁠⁠⁠https://parentingaces.com/shop/category/consult-with-lisa-stone/⁠⁠⁠⁠⁠⁠⁠⁠.If you're so inclined, please share this – and all our episodes! – with your fellow tennis players, parents, and coaches. You can subscribe to the podcast on Apple Podcasts or via your favorite podcast app. Please be sure to check out our logo'd merch as well as our a la carte personal consultations in our ⁠⁠⁠online shop⁠⁠⁠.CREDITSIntro & Outro Music: Morgan Stone aka STØNEAudio & Video Editing: Lisa Stone

The prescription of pain medication among Irish patients, including highly addictive opioids, is rapidly rising, according to new research.The use of opioids has increased by 25 per cent in Ireland, while the prescription of paracetamol rose 50 per cent between 2014-2022, according to a study published last week in the British Journal of Clinical Pharmacology.The prescription of even stronger medication, like codeine and opioids including tapentadol and oxycodone, is rising even higher.This sharp increase in pain medication prescriptions by doctors in Ireland contrasts starkly with the approach in England, where the NHS is cracking down on the overuse of these potentially-addictive medicines.Why are so many doctors prescribing this heavy-dose medication?And is this growing reliance on opioids at risk of become an addiction crisis for patients seeking pain relief?Today, on In The News, is Ireland heading towards an opioid addiction crisis?Royal College of Surgeons Ireland (RCSI) associate professor Frank Moriarty, who co-authored the study into how pain is treated in Ireland, discusses the significant rise in opioid prescriptions.Presented by Sorcha Pollak. Produced by Andrew McNair. Hosted on Acast. See acast.com/privacy for more information.

Kristin is winding down her ADHD & addiction series for now with a discussion about the comorbidity rates of substance use disorder (SUD) for ADHDers. She's covering the potential for stimulant misuse, why treating the ADHD first is crucial for SUD recovery, and how to approach treatment with a focus on harm reduction.   Plus, Kristin has a new enemy (it's always nice to have something to hate), Grace is a responsible planner for once (kinda), and we introduce a BOD that just may be the new autistic superhero of a generation.    References: SAMHSA Advisory Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder | The British Journal of Psychiatry | Cambridge Core Drug Scheduling The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders - PMC Randomized Controlled Trial of Osmotic-Release Methylphenidate with CBT in Adolescents with ADHD and Substance Use Disorders - PMC Substance Abuse Treatment with Comorbid ADHD: A Clinician's Guide 14 Kakapo Facts - Fact Animal KAKAPO Adult male 'chinging' call to attract females

Nat Ward lives in Queens, NY. His work is collected by the Museum of Modern Art, the Guggenheim Museum, the Metropolitan Museum of Art, The Parrish Art Museum, and the Museum of Fine Arts Houston. His previous book of photographs and poetry, Big Throat, was published by +KGP in 2020. Ward founded the collaborative photographic project space A New Nothing with Ben Alper in 2014 and has had features on his photographic work published in Aperture, Interview, Collector Daily, Photobook Journal, Photography & Culture, C4, The British Journal of Photography, Unseen, Vogue, Vogue Italia, Vice, and Juxtapoz. He has exhibited photographic and text-based installations at Nathalie Karg Gallery, New York Live Arts, Hampshire College, and The Jewish Museum. Ward has been awarded residencies and fellowships from Yaddo, The Cooper Union Professional Development Fund, the Edward F. Albee Foundation, and The Sharpe-Walentas Studio Program. His poetry and critical writing have appeared in publications from Wendy's Subway, 1080Press, The Brooklyn Review, and Beautiful Days Press. Ward's poems appear alongside photographs by Sara J. Winson and Aaron Canopy in Shades, published by Push Pull Editions (2024). Ward holds an MFA in Visual Art from Columbia University and an MFA in Poetry from Brooklyn College. https://nat-ward.com https://www.instagram.com/mrnatward/ https://powerhousebooks.com/books/ditch-montauk-new-york-11954/ This podcast is sponsored by the Charcoal Book Club Begin Building your dream photobook library today at https://charcoalbookclub.com

In this episode, we delve into the fascinating world of canine nutrition, focusing on the role of carbohydrates in a dog's diet. Discover how our furry friends, as facultative carnivores, have evolved to adapt to a mixed diet, including carbs, unlike their wolf ancestors. I explore the genetic differences that enable dogs to digest starches and the impact of carbs on their health and behavior. Tune in to learn about the balance between meat and plant-based foods, and how to make informed choices for your dog's diet. #DogNutrition #DogsAndCarbs

Topics include: How to find suitable journals; how to respond to reviews; the role of journals in acdemic discourse; the policies and politics of journals. Discussants: Silvia Figueirôa is Professor at the University of Campinas, Brazil, and has edited several collective volumes. Joseph D. Martin is Associate Professor at Durham University, UK, chair of the editorial board of Historical Studies in the Natural Sciences, editor-in-chief of Physics in Perspective, and book reviews editor for the British Journal for the History of Science. Doubravka Olšáková is Senior Researcher in History at Charles University in Prague, Czech Republic, and deputy editor of Centaurus. Tiago Saraiva is Full Professor of History at the Drexel University, USA, co-editor of History and Technology and a member of the Cambridge History of Technology editorial team. Recorded on March 27, 2025. For more information visit: https://www.chstm.org/node/78650

Well, well, well, it’s time to prove things.

In this episode, we break down one of the most misunderstood parts of training, lifting heavy. Whether you're a runner, a beginner, or someone looking to build strength safely, you'll learn how to start lifting with proper form, build confidence under the bar, and use science-backed strategies like progressive overload and optimal rest.We'll cover everything from movement mastery to how many days a week you actually need to train, and why heavy lifting isn't just safe, but essential for long-term performance, injury prevention, and metabolic health.To close, we shift into a 10-minute mini mindset reset on creating a training routine you'll actually stick with. You'll walk away with tangible mindset tools, flexible structure, and habits that keep you showing up, even when life gets messy.www.trainmk.com@melissa_kendter- A 2014 systematic review and meta-analysis in the British Journal of Sports Medicine- The LIFTMOR trial (2017)- https://pubmed.ncbi.nlm.nih.gov/24100287/- https://pubmed.ncbi.nlm.nih.gov/30131332/

This week's episode exemplifies the difference between Neil and Dave.Neil reads the British Journal of Psychology to research his incredible facts. Dave reads the paper in which he got his fish and chips.Nevertheless, Dave‘s fishy facts will wow you but not as much as the story of the Irish man who named a fruit and invented hot chocolate. Neil reveals how the price of a bottle of Coca-Cola remained the same for more than 70 years and greatly excited Dave with his talk of 40-foot container standardisation. Add to this the sexual tension of a seed travelling through an armadillo's alimentary canal and you've got yourself an episode.To listen to Dave on the radio check outhttps://www.todayfm.com/shows/dave-moore-1499732 To see Neil on his current tour check outhttps://www.neildelamere.com/britain-achilles-neil-tour-datesPresented and Produced by Neil Delamere and Dave MooreEdited by Nicky RyanMusic by Dave MooreArtwork by Ray McDonnell Hosted on Acast. See acast.com/privacy for more information.

Get YDS Merch before July 25!!Support us on Patreon!This week on Your Diet Sucks, we're talking hormones: what they are, what they do, and why they've become the latest scapegoat for every diet culture grift on the internet. From adrenal fatigue (not real) to seed cycling (also not real), Zoë and Kylee cut through the pseudoscience and explain what actually supports hormone health—like eating enough, managing stress, and getting some damn sleep. We also take a look at the unhinged history of hormone manipulation (yes, monkey testicle transplants come up), why cortisol isn't your enemy, and what to do if your hormones actually feel off. If you've ever been told to “balance your hormones” with a supplement stack or juice cleanse, this episode is for you.Thanks to our sponsors:Get over 70 biomarkers analyzed and get personalized nutrition recommendations adn support, tailored specifically for athletes with Eternal's new Foundations membership. Try Tailwind's limited edition blueberry lemonade! Use YOURDIET20 for 20% OFF first order.Check out Janji's new summer shorts, sports bras, packs, and more! Use code YDS10 for 10% off!Run, bike, ski, with Microcosm Coaching. We coach humans, not just athletes. Book a free consultation call today!ReferencesBayliss, W. M., & Starling, E. H. (1902). The mechanism of pancreatic secretion. The Journal of Physiology, 28(5), 325–353. https://doi.org/10.1113/jphysiol.1902.sp000911Cadegiani, F. A., & Kater, C. E. (2016). Adrenal fatigue does not exist: A systematic review. BMC Endocrine Disorders, 16, 48. https://doi.org/10.1186/s12902-016-0128-4Cohen, P. A., Avula, B., Venhuis, B., Travis, J. C., Wang, Y. H., & Khan, I. A. (2014). Pharmaceutical ingredients in botanical dietary supplements: A review of the literature. Drug Testing and Analysis, 6(7–8), 587–596. https://doi.org/10.1002/dta.1525Duggan, C., Carbo, J. M., Wang, C. Y., et al. (2015). Effects of carbohydrate intake on the thyroid axis and reproductive hormones in healthy adults: A randomized controlled feeding study. Nutrition Journal, 14, 70. https://doi.org/10.1186/s12937-015-0054-6Hamilton-Reeves, J. M., Vazquez, G., Duval, S. J., Phipps, W. R., Kurzer, M. S., & Messina, M. J. (2010). Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: Results of a meta-analysis. Fertility and Sterility, 94(3), 997–1007. https://doi.org/10.1016/j.fertnstert.2009.04.038Kantor, E. D., Rehm, C. D., Du, M., White, E., & Giovannucci, E. L. (2016). Trends in dietary supplement use among US adults from 1999–2012. JAMA, 316(14), 1464–1474. https://doi.org/10.1001/jama.2016.14403Messina, M. (2010). Insights gained from 20 years of soy research. The Journal of Nutrition, 140(12), 2289S–2295S. https://doi.org/10.3945/jn.110.124107Mountjoy, M., Sundgot-Borgen, J., Burke, L., et al. (2018). International Olympic Committee (IOC) consensus statement on relative energy deficiency in sport (RED-S): 2018 update. British Journal of Sports Medicine, 52(11), 687–697. https://doi.org/10.1136/bjsports-2018-099193Ross, A. C., Caballero, B. H., Cousins, R. J., Tucker, K. L., & Ziegler, T. R. (Eds.). (2020). Modern nutrition in health and disease (12th ed.). Wolters Kluwer.Takamine, J. (1901). The isolation of the active principle of the suprarenal gland. The Journal of the American Medical Association, 36(24), 1698–1698. https://doi.org/10.1001/jama.1901.02470350030010

From collagen powders to $100 creams, the skincare industry thrives on promises. However, many of the products we rely on for younger, healthier skin are built on shaky evidence. In this episode, world-renowned dermatologist Professor John McGrath breaks down what's real and what's not. We explore how skin truly ages, what happens beneath the surface, and why some popular treatments don't do what they claim. John dismantles three of the biggest myths in skincare, including the truth about SPF, collagen, and “bio-active” ingredients that never make it past the top layer of your skin. Professor McGrath is a Professor of Molecular Dermatology at King's College London and editor of the British Journal of Dermatology. His research has transformed how we understand genetic skin disorders and vitamin D's role in skin health. This conversation is packed with surprising insights - and one daily step that really does support healthier skin as you age.